spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  periodontal disease 

 HSMN NewsFeed - 13 Jul 2020
Landmark Head-to-Head Study Published in Journal of Periodontology Concludes That BIOLASE REPAIR(R) Perio Protocol is Superior for Procedure Time and Patient-Reported Outcomes
Devices Dental
 HSMN NewsFeed - 4 May 2020
SutroVax Appoints Andrew Guggenhime as Chief Financial Officer and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2020
SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Mar 2020
BIOLASE Announces Regulatory Clearance of Laser Bacterial Reduction Therapy Indication for Epic Hygiene Laser
Devices Dental FDA
 HSMN NewsFeed - 12 Dec 2019
European Commission Approves EVENITY(R) (romosozumab) For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Sep 2018
FDA Grants Profounda Inc. Competitive Generic Therapy (CGT) Designation for planned ANDA filing of Minocycline Hydrochloride Microspheres,1 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 8 Jun 2018
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Apr 2018
Amgen Receives Positive CHMP Opinion To Expand Use Of Prolia(R) (denosumab) To Patients With Glucocorticoid-Induced Osteoporosis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Feb 2018
Amgen Receives Positive Opinion Expanding Use Of XGEVA(R) (denosumab) To Cover Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma In Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 10 Dec 2012
ApniCure Appoints David P. White, M.D., as Chief Scientific Officer
Devices Personnel
 HSMN NewsFeed - 18 May 2012
ApniCure Receives FDA 510(k) Clearance to Market Winx(TM) Sleep Therapy System for Treatment of Obstructive Sleep Apnea
Devices FDA
 HSMN NewsFeed - 14 Dec 2011
Interleukin Genetics Appoints Lynn Doucette-Stamm Vice President of Development
Diagnostics Personnel
 HSMN NewsFeed - 9 Nov 2011
Systagenix Adds Two Members to Board of Directors
Devices Wound Care Personnel
 HSMN NewsFeed - 16 Jun 2010
Lantis Laser Signs Letter of Intent to Merge With Perio-Imaging Inc.
Devices Dental Mergers & Acquisitions
 HSMN NewsFeed - 16 Mar 2010
BIOLASE Announces FDA 510(K) Clearance of iLase (TM) Personal Laser for Dental Market
Devices Dental FDA
 HSMN NewsFeed - 5 Mar 2009
Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 20 Aug 2008
PathoLase, Inc. Appoints Skip Phairas as Chief Operating Officer
Devices Personnel
 HSMN NewsFeed - 5 Aug 2008
Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 29 Apr 2008
Medtronic and Scil Technology Establish Partnership for Dental Bone Regeneration Therapies
Devices Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 21 Apr 2008
BioMimetic Therapeutics Receives Written Communication from FDA Confirming Status of Ongoing Pivotal Trial for GEM OS1
Devices Orthopaedic
 HSMN NewsFeed - 28 Mar 2008
BioMimetic Therapeutics Addresses FDA Communication on Regranex Safety Review
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 14 Mar 2008
Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 14 Feb 2008
QuantRx(R) Biomedical Announces Second Agreement With ALT BioScience to Develop Diagnostic Tests for Oral Health
Diagnostics
 HSMN NewsFeed - 16 Jan 2008
Pfizer and Scil Finalize Agreement for Novel Cartilage Growth Factor
Biopharmaceuticals Regenerative Medicine Licensing
 HSMN NewsFeed - 15 Jan 2008
Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 8 Jan 2008
Isolagen Inc. Promotes Declan Daly to Chief Executive Officer (CEO)
Regenerative Medicine Personnel
 HSMN NewsFeed - 1 Nov 2007
Dawn McGuire, M.D. Joins Acologix, Inc. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Oct 2007
Zila Adds David Goldman to Board of Directors
Devices Diagnostics Oncology Personnel
 HSMN NewsFeed - 6 Jul 2007
Isolagen, Inc. Promotes Declan Daly to Chief Operating Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 5 Mar 2007
Obagi Medical Products and Dongkook Pharmaceuticals Announce Launch of Obagi Nu-Derm System Skincare Products in South Korea
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 13 Feb 2007
Millennium Dental Technologies Announces the Hiring of Tom Haney as VP of Business Development
Devices Dental Personnel
 HSMN NewsFeed - 20 Dec 2006
CollaGenex Pharmaceuticals Signs License and Supply Agreement with MediGene for Marketing Rights to Oracea in EU and Certain Other Countries
Biopharmaceuticals Dermatology Licensing
 HSMN NewsFeed - 30 May 2006
CollaGenex Pharmaceuticals Receives FDA Approval for Oracea(TM)
Biopharmaceuticals Dermatology FDA
Return to NewsFeed  

 Additional items found! 45

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 45 additional stories matching:
periodontal disease
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.